Evidence map›Paper›PMID 35071002›Full record

ArticleFrontiers in oncology2021

Yi Zhang, Min Ji, Jin-Yan Zhao, Hua-Feng Wang, Chong-Wu Wang, Wei Li, Jing-Jing Ye, Fei Lu, Li-Hui Lin, Yan-Ting Gao and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yi ZhangDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Min JiDepartment of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Jin-Yan ZhaoDepartment of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hua-Feng WangDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Chong-Wu WangR & D Department, Hosea Medical Technology (Beijing) Co., Ltd., Beijing, China.
Wei LiDepartment of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Jing-Jing YeDepartment of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Fei LuDepartment of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Li-Hui LinDepartment of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yan-Ting GaoDepartment of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jie JinDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Li LiDepartment of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chun-Yan JiDepartment of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Joan BallesterosR & D Department, Vivia Biotech, Madrid, Spain.
Hong-Hu ZhuDepartment of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the predictive value of the

Indexed as

acute myeloid leukemiachemosensitivitycomplete remissionex vivo drug sensitivity testprecision medicine

Identifiers

PMID35071002
PMCPMC8767104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.